Equivalence of the acute cytokine surge and myocardial injury after coronary artery bypass grafting with and without a novel extracorporeal circulation system

Journal of International Medical Research

Volumn 33, Issue 2, 2005, Pages 133-149

  Murakami, T ^a   Iwagaki, H ^b   Saito, S ^b   Ohtani, S ^a   Kuroki, K ^c   Kuinose, M ^a   Tanaka, N ^b   Tanemoto, K ^d  

^a IWAKUNI NATIONAL HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION FUKUYAMA MEDICAL CENTER   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Complement activation; Coronary artery bypass grafting; Creatine kinase; Cytokines; Leucocyte elastase; Minimal extracorporeal circulation system; Troponin T

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ANASTOMOSIS; ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; GRAFT FAILURE; HEART ATRIUM FIBRILLATION; HEART MUSCLE INJURY; HUMAN; INFLAMMATION; MALE; MENTAL DISEASE; OFF PUMP CORONARY SURGERY; POSTOPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STENOSIS; STOMACH HEMORRHAGE; SURGICAL TECHNIQUE; TRANSIENT ISCHEMIC ATTACK;

EID: 14944349706     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000503300201     Document Type: Article

References (51)

1. Ohata T, Sawa Y, Kadoba K, Masai T, Ichikawa H, Matsuda H: Effect of cardiopulmonary bypass under tepid temperature on inflammatory reactions. Ann Thorac Surg 1997; 64: 124-128.
2. Edmunds LH, Jr: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998; 66 (Suppl. 5): S12-S16.
3. Asimakopoulos G, Taykor KM: Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg 1998; 66: 2135-2144.
4. Moen O, Hogasen K, Fosse E, Dregelid E, Brockmeier V, Venge P, et al: Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997; 63: 105-111.
5. Gott JP, Cooper WA, Schmidt FE, Jr, Brown WM, Wright CE, Merlino JD, et al: Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg 1998; 66: 747-753.
6. Horton SB, Butt WW, Mullaly RJ, Thuys CA, O'Connor EB, Byron K, et al: IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating. Ann Thorac Surg 1999; 68: 1751-1755.
7. Ascione R, Lloyd CT, Gomes WJ, Caputo M, Bryan AJ, Angelini GD: Beating versus arrested heart revascularization: evaluation of myocardial function in a prospective randomized study. Eur J Cardiothorac Surg 1999; 15: 685-690.
8. Buffolo E, de Andrade CS, Branco JN, Teles CA, Aguiar LF, Gomes WJ: Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 1996; 61: 63-66.
9. Poirier NC, Carrier M, Lesperance J, Cote G, Pellerin M, Perrault LP, et al: Quantitative angiographic assessment of coronary anastomoses performed without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 117: 292-297.
10. Wan S, Izzat MB, Lee TW, Wan IY, Tang NL, Yim AP: Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 1999; 68: 52-57.
11. Matata BM, Sosnowski AW, Galinanes M: Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 2000; 69: 785-791.
12. Wei M, Kuukatsjarvi P, Laurikka J, Kaukinen S, Iisalo P, Laine S, et al: Cytokine responses and myocardial injury in coronary artery bypass grafting. Scand J Clin Lab Invest 2001; 61: 161-166.
13. Gulielmos V, Menschikowski M, Dill H, Eller M, Thiele S, Tugtekin SM, et al: Interleukin-1, interleukin-6 and myocardial enzyme response after coronary artery bypass grafting - a prospective randomized comparison of the conventional and three minimally invasive surgical techniques. Eur J Cardiothorac Surg 2000; 18: 594-601.
14. Diegeler A, Doll N, Rauch T, Haberer D, Walther T, Falk V, et al: Humoral immune response during coronary artery bypass grafting. A comparison of limited approach, 'off-pump' technique, and conventional cardiopulmonary bypass. Circulation 2000; 102 (Suppl 3): 95-100.
15. Schulze C, Conrad N, Schutz A, Egi K, Reichenspurner H, Reichart B, et al: Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting. Thorac Cardiovasc Surg 2000; 48: 364-369.
16. Englberger L, Kipfer B, Berdat PA, Nydegger UE, Carrel TP: Aprotinin in coronary operation with cardiopulmonary bypass: does 'low-dose' aprotinin inhibit the inflammatoryresponse? Ann Thorac Surg 2002; 73: 1897-1904.
17. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD: Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 1198-1204.
18. Chello M, Mastroroberto P, Quirino A, Cuda G, Perticone F, Cirillo F, et al: Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass. Ann Thorac Surg 2002; 73: 123-130.
19. Gormley SM, McBride WT, Armstrong MA, McClean E, MacGowan SW, Campalani G, et al: Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Cytokine 2002; 17: 61-65.
20. Fransen E, Maessen I, Dentener M, Senden N, Geskes G, Buurman W: Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 1998; 113: 1290-1295.
21. Brasil LA, Gomes WJ, Salomao R, Buffolo E: Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 1998; 66: 56-59.
22. Westaby S: Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987; 13: 89-95.
23. Downing SW, Edmunds LH, Jr: Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 1236-1243.
24. Baigrie RJ, Lamont PM, Dallman M, Morris P: The release of interleukin-1 beta precedes that of interleukin-6 in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108: 636-641.
25. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108: 636-641.
26. Ruvolo G, Greco E, Speziale G, Tritapepe L, Merino B, Mollace V, et al: Nitric oxide formation during cardiopulmonary bypass. Ann Thorac Surg 1994; 57: 1055-1057.
27. Ungureannu-Longrois D, Balligand JL, Kelly RA, Smith TW: Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 1995; 27: 155-167.
28. Kubes P, Suzuki M, Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991; 88: 4651-4655.
29. Niu XF, Smith CW, Kubes P: Intercellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994; 74: 1133-1140.
30. Harig F, Feyrer R, Mahmoud FO, Blum U, von der Emde J: Reducing the post-pump syndrome by using heparin-coated circuits, steroids or aprotinin. Thorac Cardiovasc Surg 1999; 47: 111-118.
31. Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt MF, Deleuze P, et al: Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002; 22: 527-533.
32. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 1992; 89: 4845-4949.
33. Weis M, Wildhirt S, Schulze C: Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients. Transplantation 1999; 68: 1263-1267.
34. Engelberts I, Stephens S, Francot GJ, van der Linden CJ, Buurman WA: Evidence for different effects of soluble TNF-receptors on various TNF-measurements in human biological fluids. Lancet 338: 515-516.
35. Fong Y, Lowry SF: Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 1990; 55: 157-170.
36. Hatori N, Yoshizu H, Haga Y, Kusama Y, Takeshima S, Segawa D, et al: Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass. Artif Organs 1994; 18: 904-910.
37. Gu Y, van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CR: Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 917-922.
38. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M: Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234-241.
39. Rollins BJ: Chemokines. Blood 1997; 90: 909-928.
40. Ivey CL, Williams FM, Collins PD, Jose PJ, Williams TJ: Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit: evidence for a role for C5a and interleukin-8. J Clin Invest 1995; 95: 2720-2728.
41. Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ, et al: Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995; 95: 89-103.
42. Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL: Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112: 806-811.
43. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, et al: Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92: 748-755.
44. Boyle EM, Jr, Kovacich JC, Hebert CA, Canty TG, Jr, Chi E, Morgan EN, et al: Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg 1998; 116: 114-121.
45. Kawamura T, Nara N, Kadosaki M, Inada K, Endo S: Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery. Crit Care Med 2000; 28: 2201-2208.
46. Markewitz A, Faist E, Lang S, Hultner L, Weinhold C, Reichart B: An imbalance in T-helper cell subsets alters immune response after cardiac surgery. Eur J Cardiothorac Surg 1996; 10: 61-67.
47. Bauman H, Gauldie J: The acute phase response. Immunol Today 1994; 15: 74-80.
48. Barton BE, Jackson JV: Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993; 61: 1496-1499.
49. Vertrees R, Tao W, Kramer GC, Nutt L, McDaniel LB, DeVine SD, et al: Tumor necrosis factor monoclonal antibody prevents alteration in leukocyte populations during cardiopulmonary bypass. ASAIO J 1994; 40: 554-559.
50. Kawamura T, Wakusawa R, Okada K, Inada S: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin-8 and 6 in reperfusion injury. Can J Anaesth 1993; 40: 1016-1021.
51. Hayashi Y, Sawa Y, Fukuyama N, Nakazawa H, Matsuda H: Inducible nitric oxide production is an adaptation to cardiopulmonary bypass-induced inflammatory response. Ann Thorac Surg 2001; 72: 149-155.